First Tracks Biotherapeutics, Inc.
NASDAQFirst Tracks Biotherapeutics enters the week of May 11 with a stark contradiction at its centre: six Wall Street firms initiated coverage in the past month with unanimous bullish ratings, yet the stock has shed 31% over the same period — a gap that defines the story heading into the June 1 earnings event. The Street's opening salvo was emphatic. JP Morgan kicked off coverage on…
Snapshot as of 16 May 2026
First Tracks Biotherapeutics enters the week of May 11 with a stark contradiction at its centre: six Wall Street firms initiated coverage in the past month with unanimous bullish ratings, yet the stock has shed 31%…
TRAX — First Tracks Biotherapeutics — enters the weekend carrying two stories in direct tension: one of the more aggressive analyst coverage launches seen for a small-cap biotech, and a Friday-evening resale prospectus…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for TRAX — free to start on ORTEX.
Sign up for free →Open TRAX on ORTEX